Prof. Ofer Mandelboim

Prize for an Established Researcher
Natural Killer (NK) cells are part of the innate immune system, and as specialized first responder cells they can eliminate cancerous cells, virally infected cells, and deleterious pathogens. Understanding how NK cells recognize such diverse targets has remained a challenge for many years. Furthermore, scientists are still investigating the many mechanisms employed by these deleterious targets to evade detection by NK cells. Vigorous work by Professor Ofer Mandelboim and his colleagues from the Concern Foundation laboratories at the Lautenberg Center of the Medical Faculty at the Hebrew University of Jerusalem, led to the discovery of the ways NK cells recognize many important viruses, including influenza and the human cytomegalovirus. Moreover, this team of investigators uncovered how NK cells recognize bacteria and fungi; an important step forward for clinical research, since many of these pathogens are currently untreatable. In addition, the investigators discovered how NK cells recognize and kill different cancers, and concomitantly how these cancers evade elimination by NK cells. 
These discoveries led to the creation of novel immunotherapies aimed at enhancing the NK cells’ capability to combat these cancers. The immunotherapies are currently being developed by various companies, some established by Prof. Mandelboim and his colleagues, which are located both in Israel and abroad. Excitingly, some of these immunotherapies are already being tested on humans in clinical trials, and others are presently in the developmental stage.
Share by: